InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160
$2.64 +5.18% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.64 −96.57% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Apr 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−46.8Net income−45.7EPS, diluted−8.16Fiscal year 2020Operating income−118.8Net income−117.8EPS, diluted−4.19Fiscal year 2021Operating income−216.5Net income−158.7EPS, diluted−3.72Fiscal year 2022Revenue0.0Operating income−227.3Net income−236.8EPS, diluted−4.48Fiscal year 2023Revenue0.0Operating income−299.5Net income−292.2EPS, diluted−4.47Fiscal year 2024Revenue67.4Operating income−191.2Net income−165.8EPS, diluted−2.33Fiscal year 2025Revenue0.0 −100.0%Operating income−152.8Net income−137.1EPS, diluted−1.91
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 0.0 0.0 67.4 0.0
Growth −100.0%
Operating income −46.8 −118.8 −216.5 −227.3 −299.5 −191.2 −152.8
Net income −45.7 −117.8 −158.7 −236.8 −292.2 −165.8 −137.1
Growth
EPS, diluted −8.16 −4.19 −3.72 −4.48 −4.47 −2.33 −1.91

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin−283.6%Net margin−246.0%Free cash flow margin−253.7%Fiscal year 2025
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a −283.6% n/a
Net margin n/a n/a n/a n/a n/a −246.0% n/a
Free cash flow margin n/a n/a n/a n/a n/a −253.7% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−39.1Capital expenditure−0.4Free cash flow−39.5Fiscal year 2020Operating cash flow−86.8Capital expenditure−0.8Free cash flow−87.6Fiscal year 2021Operating cash flow−154.1Capital expenditure−6.1Free cash flow−160.2Fiscal year 2022Operating cash flow−163.8Capital expenditure−2.5Free cash flow−166.3Fiscal year 2023Operating cash flow−207.8Capital expenditure−0.6Free cash flow−208.4Buybacks0.0Fiscal year 2024Operating cash flow−170.9Capital expenditure−0.2Free cash flow−171.1Buybacks0.0Fiscal year 2025Operating cash flow−125.2Capital expenditure0.0Free cash flow−125.2Buybacks−10.0
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −39.1 −86.8 −154.1 −163.8 −207.8 −170.9 −125.2
Capital expenditure −0.4 −0.8 −6.1 −2.5 −0.6 −0.2 0.0
Free cash flow −39.5 −87.6 −160.2 −166.3 −208.4 −171.1 −125.2
Growth
Buybacks n/a n/a n/a n/a 0.0 0.0 −10.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash67.2Shareholders’ equity−73.3Fiscal year 2020Cash55.0Shareholders’ equity308.6Fiscal year 2021Cash59.7Shareholders’ equity364.0Fiscal year 2022Cash43.1Shareholders’ equity433.8Fiscal year 2023Cash28.0Shareholders’ equity437.3Fiscal year 2024Cash33.9Shareholders’ equity337.2Fiscal year 2025Cash36.0Shareholders’ equity216.2
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 67.2 55.0 59.7 43.1 28.0 33.9 36.0
Shareholders’ equity −73.3 308.6 364.0 433.8 437.3 337.2 216.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
67.2 55.0 59.7 43.1 28.0 33.9 36.0
0.1 0.4 0.0 n/a 0.0 5.0 0.0
0.5 1.1 8.1 7.7 5.8 4.7 2.8
3.7 3.7 3.7 3.7 3.7 0.0 n/a
87.5 365.6 454.5 539.3 551.7 430.3 289.0
Growth +317.9% +24.3% +18.7% +2.3% −22.0% −32.9%
Liabilities
19.1 32.2 90.0 105.3 114.3 93.2 72.8
Equity
−83.0 −200.8 −359.6 −596.4 −888.6 −1,054.4 −1,191.5
−73.3 308.6 364.0 433.8 437.3 337.2 216.2
Growth +17.9% +19.2% +0.8% −22.9% −35.9%
Per share and net cash
n/a 41.0 45.5 59.3 70.8 71.3 69.1
calc n/a 7.52 8.00 7.32 6.18 4.73 3.13

† The diluted share count jumps at 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.